We work with globally recognized pharmaceutical manufacturers operating across 100+ countries and certified by leading regulatory bodies such as the WHO, EMA, MHRA, and others.

These partnerships enable access to a robust portfolio of affordable, high-quality treatments across 70+ therapeutic areas including essential medicines, vaccines, and biologics tailored to the needs of the Saudi and regional markets.

With more than 600 generic formulations across six continents, our partners support a consistent, scalable supply of SFDA-compliant solutions that meet national priorities and international standards.

This breadth of access empowers Human Health to rapidly respond to evolving market needs, ensuring reliability, efficiency, and a commitment to better health for all.